Latest 8-K filings

Royal Caribbean Cruises Ltd. has entered into an underwriting agreement to issue and sell $1.25 billion in aggregate principal amount of 5.550% Senior Notes due 2034.

Dauch Corporation announced robust second quarter 2026 financial results, driven by its recent acquisition, with significant increases in sales and operating cash flow, alongside an improved full-year financial outlook.

Gyre Therapeutics announced its second quarter 2026 financial results, reporting $29.1 million in revenue and affirming full-year revenue guidance, while also detailing progress on its pipeline and the acquisition of Cullgen.

PPL Corporation announced strong second-quarter 2026 financial results, exceeding prior year earnings and reaffirming its full-year guidance and long-term growth targets.

Wheeler Real Estate Investment Trust adjusts convertible note conversion price significantly downward following preferred stock redemptions, leading to substantial common stock issuance.

DENTSPLY SIRONA Inc. filed an amendment to its Form 8-K to correct an EDGAR description tag, confirming its second quarter 2026 financial results and reiterating its full-year outlook.

Take-Two Interactive reported Q1 FY27 results with net bookings slightly above guidance, driven by strong recurrent consumer spending, and reiterated its full-year outlook, anticipating the Grand Theft Auto VI launch.

ACM Research announced robust second quarter 2026 financial results, with revenue and shipments up 36% year-over-year, and raised its full-year revenue outlook to 25%-30% growth.

Alpha Metallurgical Resources presented its investor overview for August 2026, detailing operational performance, market outlook, and financial summary, including guidance for the remainder of 2026.

Telephone and Data Systems, Inc. announced its second quarter 2026 results, highlighting growth in TDS Telecom's fiber footprint and Array's site rental revenue, alongside updated financial guidance for both segments.

Array Digital Infrastructure announced robust second quarter 2026 results, featuring a 90% surge in total operating revenues and a significant increase in net income, alongside updated positive financial guidance for the full year.

Alpha Metallurgical Resources announced a net loss of $12.3 million for the second quarter of 2026, with Adjusted EBITDA falling to $25.6 million, impacted by lower shipment volumes and higher costs.

Under Armour reported a 3% revenue decrease for Q1 FY27, driven by North America, while maintaining its full-year profitability outlook despite updating revenue expectations.

The E.W. Scripps Company reported a $1.2 billion net loss for Q2 2026, driven by a $1.1 billion goodwill impairment charge, while revenue declined 9.2% year-over-year.

Kimbell Royalty Partners LP announced record-breaking second quarter 2026 results, including record revenues, net income, Adjusted EBITDA, and production, alongside a 15% increase in cash distribution.

Douglas Elliman reported a 4.5% year-over-year revenue increase in Q2 2026, with operating and net losses narrowing, driven by strategic growth initiatives including AI transformation and market expansion.

Sylvamo announced a second quarter net loss of $11 million, with adjusted EBITDA of $60 million, as it navigates strategic investments, supply chain adjustments, and external market pressures.

Minerva Neurosciences reported second quarter 2026 financial results and business updates, highlighting ongoing Phase 3 trial progress for roluperidone while financial performance was significantly impacted by non-cash warrant liability adjustments.

Treace Medical Concepts, Inc. reported second quarter 2026 revenue of $45.4 million, a 4% decrease year-over-year, alongside a net loss of $15.9 million, though the company raised its full-year Adjusted EBITDA guidance.

Embecta Corp. reported third quarter fiscal year 2026 financial results, showing a year-over-year revenue decrease of 8.1% to $271.7 million, though sequential revenue improved by $50 million.

Wendy's announced second-quarter 2026 results showing a decline in global systemwide sales and net income, leading to a withdrawal of its 2026 outlook and a reduction in its quarterly dividend.

Canopy Growth announced its first quarter fiscal year 2027 financial results, reporting a 13% increase in consolidated net revenue to $81.2 million and a 59% reduction in Adjusted EBITDA loss.

Kiora Pharmaceuticals announced its second quarter 2026 financial results, highlighting progress in its Phase 2 trials for KIO-301 and KIO-104, and an extended operational runway into late 2028.

Mobility Global Inc. announced strong second quarter 2026 financial results, including a 7% revenue increase and the initiation of a quarterly cash dividend.

Rapid Micro Biosystems reported an 11% increase in second-quarter revenue to $8.1 million and a significant improvement in gross margin to 15%, while reaffirming full-year guidance.

LCI Industries announced a regular quarterly cash dividend of $1.15 per share, payable on September 4, 2026.

Fluor Corporation announced robust second quarter 2026 financial results, highlighted by $6.1 billion in new awards and a significant increase in segment profit, while narrowing its full-year adjusted EBITDA guidance.

NRx Pharmaceuticals reports progress on its preservative-free ketamine ANDA, with the FDA identifying no major drug-component deficiencies but requesting clarification on vial packaging.

Vistra Corp. announced robust second quarter 2026 financial results, showcasing over 30% growth in Ongoing Operations Adjusted EBITDA and reaffirming full-year guidance.

Starz Entertainment Corp. reported its second-quarter 2026 financial results, announcing an increased outlook for Adjusted OIBDA and Unlevered Free Cash Flow, while reaffirming its year-end leverage target.